Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer Newly diagnosed patients with cT2-4N0-2M0 HNC were ...
FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...
Liberate Medical completes enrollment of its 250-patient PREVENT pivotal trial evaluating VentFree, a breakthrough ventilator weaning device for ICUs.
A new multicenter clinical trial published in Diabetes, Obesity & Metabolism suggests that intensifying treatment with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results